CD3 Competitors and Similar CompaniesClear all
CD3's competitors and similar companies include Genentech, Cipla, Livzon Pharmaceutical Group and CSL Behring.
 CD3 CD3 (Centre for Drug Design and Discovery) is an investment fund aimed at promoting the discovery and development of medicines for various kinds of diseases. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2006 | Founding Date 1976 | Founding Date 1935 | Founding Date 1985 | Founding Date 1904 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Leuven, BE HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 32 | Employees 18,077 | Employees 27,764 | Employees 9,067 | Employees 7,5692% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹195b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income N/A | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Trademark Applications | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications 1 (Dec, 2020) |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks 4 (Dec, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Genentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company